Kawanishi Y, Harada S, Tachikawa H, Okubo T, Shiraishi H
Department of Psychiatry, University of Tsukuba, Ibaraki, Japan.
J Hum Genet. 2000;45(1):24-30. doi: 10.1007/s100380050005.
The transcription factor activator protein 2 (AP-2) gene is a possible candidate gene for schizophrenia, since it maps near D6S470, a marker on chromosome 6p24 that provided evidence of linkage to schizophrenia. In the present study we analyzed the promoter region and the whole coding region of the human AP-2 gene in order to identify genetic variations that may lead to the modification of AP-2 expression or the alteration of protein function, contributing to schizophrenia or particular schizophrenic phenotypes. Genomic DNA was isolated from the whole blood samples of 87 unrelated schizophrenics and 100 healthy controls. Polymerase chain reaction (PCR) was performed, using 15 primer sets that spanned the promoter region and the whole coding region, and amplified products were screened by single-strand conformational polymorphism (SSCP) analysis. Aberrant SSCP patterns were analyzed by direct sequencing. Three novel polymorphisms were found in the promoter region; two relatively common (-90G-->C, -803G-->T) and one rare (-1769G-->A). Polymorphic status at both loci suggested strong linkage disequilibrium between the -90G and -803G alleles, and between the -90C and -803T alleles. Although no significant differences in genotypic and allelic frequencies at the -90 and -803 loci were found between patients and controls, significant differences in the distribution of genotypes at the -90 (P = 0.008) and -803 (P = 0.037) loci were observed in patients with an episodic course compared with controls. However, the difference for the -803 locus was not significant after Bonferroni correction for multiple comparisons. Our data provided no direct evidence of an association between schizophrenia and the polymorphisms of the AP-2 gene, although the positive result at the -90 locus in schizophrenics with an episodic course is potentially interesting.
转录因子激活蛋白2(AP - 2)基因可能是精神分裂症的候选基因,因为它定位于D6S470附近,D6S470是位于6号染色体6p24上的一个标记,该标记为精神分裂症的连锁提供了证据。在本研究中,我们分析了人类AP - 2基因的启动子区域和整个编码区域,以确定可能导致AP - 2表达改变或蛋白质功能改变的基因变异,这些变异可能与精神分裂症或特定的精神分裂症表型有关。从87名无亲缘关系的精神分裂症患者和100名健康对照者的全血样本中分离基因组DNA。使用跨越启动子区域和整个编码区域的15对引物进行聚合酶链反应(PCR),并通过单链构象多态性(SSCP)分析筛选扩增产物。通过直接测序分析异常的SSCP模式。在启动子区域发现了三个新的多态性;两个相对常见(-90G→C,-803G→T)和一个罕见(-1769G→A)。两个位点的多态性状态表明-90G和-803G等位基因之间以及-90C和-803T等位基因之间存在强连锁不平衡。虽然在患者和对照之间未发现-90和-803位点的基因型和等位基因频率有显著差异,但与对照相比,发作性病程的患者在-90(P = 0.008)和-803(P = 0.037)位点的基因型分布存在显著差异。然而,在进行多重比较的Bonferroni校正后,-803位点的差异不显著。我们的数据没有提供精神分裂症与AP - 2基因多态性之间关联的直接证据,尽管发作性病程的精神分裂症患者在-90位点的阳性结果可能很有趣。